Ozlem Fidanci: Reflections From WHA79 on the Future of Stroke Care
Ozlem Fidanci, Chief of International Region at Philips, Member of Executive Committee, shared on LinkedIn:
”It’s been a packed and energizing week at WHA79 in Geneva, and so encouraging to see how strongly the global health conversation is shifting toward prevention, earlier diagnosis, AI-enabled care, and more resilient healthcare systems.
Over the past few days, I had the opportunity to engage with Ministers of Health, policymakers, and partners from across many of our markets on key priorities: improving access to care, strengthening health system resilience, and scaling innovation through AI and digital health.
A major milestone was the adoption of WHA resolutions on Stroke Care and Diagnostic Imaging through Teleradiology, two important areas where Philips was proud to help convene discussions and co-organize events alongside partners and governments.
For stroke care, the focus is clear: improving access to early diagnosis, timely treatment, and post-stroke care, while advancing technologies such as Mechanical Thrombectomy that can significantly improve patient outcomes.
On diagnostic imaging and teleradiology, momentum is growing around scalable digital and AI-supported solutions that can expand access to imaging, improve diagnostic confidence and speed, and enable earlier detection of disease particularly in underserved communities.
Early diagnosis remains one of the most powerful ways to improve outcomes and reduce pressure on health systems.
Another important topic was raising awareness around global helium supply volatility and the potential impact on continuity of MRI services.
Advancing helium-free and low-helium MRI solutions will be critical to building more resilient and sustainable imaging infrastructure.
I also appreciated the opportunity to join discussions at the World Economic Forum dinner on AI, digital health, pandemic preparedness, and NCDs, reinforcing the importance of collaboration across governments, industry, and global health partners.
Thank you so much to all partners and colleagues for the conversations and continued collaboration throughout the week and beyond!”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series